Prospective, randomized, multicenter, double-blind placebo-controlled trial comparing adjuvant combination therapy of interferon alfa and isotretinoin with adjuvant therapy of interferon alfa in ...
Effect of the combination of mTOR inhibitor ridaforolimus and HDAC inhibitor vorinostat on in vitro synergism in synovial sarcoma, osteosarcoma, and a range of other tumor subtypes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results